Daiichi Sankyo (PK) Stock Price

-0.66 (-2.48%)
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Daiichi Sankyo Co Ltd (PK) DSKYF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.66 -2.48% 25.92 13:47:41
Close Price Low Price High Price Open Price Previous Close
25.92 25.92 25.92 25.92 26.58
Bid Price Ask Price Spread News
25.28 25.95 0.67 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
11 528 $ 25.92 $ 13,686 640 25.65 - 95.96
Last Trade Time Type Quantity Stock Price Currency
15:55:32 19 $ 25.32 USD

Daiichi Sankyo (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 18.38B 709.01M - $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
258.98k $ - 0.00% - -

more financials information »

Daiichi Sankyo (PK) News

Real-Time news about Daiichi Sankyo Co Ltd (PK) (OTCMarkets): 0 recent articles
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical DSKYF Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week25.9826.5825.6526.291,201-0.06-0.23%
1 Month92.7692.7625.6529.201,360-66.84-72.06%
3 Months88.9695.9625.6553.60910-63.04-70.86%
6 Months68.0095.9625.6566.59875-42.08-61.88%
1 Year62.80595.9625.6566.25962-36.89-58.73%
3 Years22.7595.9622.7556.141,9193.1713.93%
5 Years19.4795.9619.0342.112,3266.4533.13%

Daiichi Sankyo (PK) Description

Founded on September 28, 2005 through the merger of Daiichi Pharmaceutical and Sankyo, Daiichi Sankyo delivers innovative products that enhance the lives of millions of people around the world. Our recent successes include the antihypertensive agent olmesartan (Olmetec®), launched in 2002 by Sankyo and now available in more than 50 countries around the world; the antiplatelet agent prasugrel (Efient®), launched in 2009 for patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI); and edoxaban (Lixiana®), the first available factor Xa inhibitor in Japan, which launched in 2011 to help prevent venous thromboembolism (VTE).
Your Recent History
Daiichi Sa..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201024 18:48:57